Publicaciones en colaboración con investigadores/as de Auckland City Hospital (1)

2019

  1. PIK3CA alterations and benefit with neratinib: Analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial

    Breast Cancer Research, Vol. 21, Núm. 1